Document Detail

Smoking among tuberculosis patients in Kerala, India: proactive cessation efforts are urgently needed.
MedLine Citation:
PMID:  18812043     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To document smoking patterns among tuberculosis (TB) patients at eight different points of time before, during and after treatment, and to investigate the frequency and content of the quit smoking messages they received. DESIGN: A stratified random sample of 215 male TB patients from Kerala, India, who had completed treatment in the previous 9 months was surveyed using a pre-tested semi-structured interview schedule. RESULTS: Six months prior to diagnosis, 94.4% of male TB patients were ever smokers and 71.2% were current smokers. Although 87% of patients had quit smoking soon after diagnosis, 36% had relapsed by 6 months post treatment. One third relapsed during the first 3 months of treatment and another third during the next 3 months of treatment. Two thirds of all smokers received cessation advice from primary care physicians, but less than half received advice from others. Less than half of all messages were TB-specific; the rest were very general short instructions. Smoking more than 15 cigarettes/bidis at the time of diagnosis was significantly associated with a lower quit rate during treatment (OR 8.0, 95%CI 2.1-30.9). CONCLUSION: Messages to not smoke often go unheeded among TB patients. Proactive efforts are needed to encourage health staff and DOTS providers to give strong cessation messages.
A S Pradeepkumar; K R Thankappan; M Nichter
Related Documents :
25052453 - Thoraco-abdominal asymmetry and asynchrony in congenital diaphragmatic hernia.
11022023 - The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acampros...
8525653 - Smoking as a risk factor for duodenal ulcer relapse. ruder study group.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease     Volume:  12     ISSN:  1027-3719     ISO Abbreviation:  Int. J. Tuberc. Lung Dis.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-09-24     Completed Date:  2009-01-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9706389     Medline TA:  Int J Tuberc Lung Dis     Country:  France    
Other Details:
Languages:  eng     Pagination:  1139-45     Citation Subset:  IM    
Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antitubercular Agents / administration & dosage
Directly Observed Therapy
India / epidemiology
Interviews as Topic
Logistic Models
Middle Aged
Risk Factors
Sampling Studies
Smoking / adverse effects*,  epidemiology*,  prevention & control*
Smoking Cessation*
Tuberculosis, Pulmonary / drug therapy,  epidemiology*
Grant Support
R01 TW005969-04/TW/FIC NIH HHS
Reg. No./Substance:
0/Antitubercular Agents
Comment In:
Int J Tuberc Lung Dis. 2008 Oct;12(10):1103   [PMID:  18812035 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment adherence of the latently infected tuberculosis population (post-Katrina) at Wetmore TB Cl...
Next Document:  Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberc...